Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 14, Issue 2, Pages 185-197
Publisher
Informa Healthcare
Online
2013-01-15
DOI
10.1517/14656566.2013.761975
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistence and compliance of medications used in the treatment of osteoporosis analysis using a large scale, representative, longitudinal German database
- (2012) Volker Ziller et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Incidence of atypical nontraumatic diaphyseal fractures of the femur
- (2012) Richard M Dell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effectiveness of Teriparatide in Postmenopausal Women with Osteoporosis and Glucocorticoid Use: 3-Year Results from the EFOS Study
- (2012) D. KARRAS et al. JOURNAL OF RHEUMATOLOGY
- A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
- (2012) S. Lekamwasam et al. OSTEOPOROSIS INTERNATIONAL
- Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial
- (2012) M Hakala et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Inflammatory Rheumatic Disorders and Bone
- (2012) Irene E. M. Bultink et al. Current Rheumatology Reports
- Clinical Question: What is the best approach to managing glucocorticoid-induced osteoporosis?
- (2011) Juliet Compston CLINICAL ENDOCRINOLOGY
- Glucocorticoid-Induced Bone Disease
- (2011) Robert S. Weinstein NEW ENGLAND JOURNAL OF MEDICINE
- Advances in Glucocorticoid-Induced Osteoporosis
- (2011) Debby den Uyl et al. Current Rheumatology Reports
- Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
- (2010) M. C. van der Goes et al. ANNALS OF THE RHEUMATIC DISEASES
- From bone biology to clinical outcome: state of the art and future perspectives
- (2010) G. Schett et al. ANNALS OF THE RHEUMATIC DISEASES
- Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?
- (2010) Steven L. Teitelbaum et al. ARTHRITIS AND RHEUMATISM
- Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation
- (2010) Joseph S Butler et al. BMC MUSCULOSKELETAL DISORDERS
- Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk
- (2010) Iván Cárcamo-Orive et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Oral bisphosphonate compliance and persistence: a matter of choice?
- (2010) S. L. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands
- (2010) J. C. Netelenbos et al. OSTEOPOROSIS INTERNATIONAL
- Compliance and persistence with osteoporosis medications: A critical review of the literature
- (2010) Stuart Silverman et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
- (2010) Jennifer M. Grossman et al. ARTHRITIS CARE & RESEARCH
- Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
- (2009) R. K. Dore et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomized Double-Blind, Placebo-Controlled Trial*
- (2009) Astrid Fahrleitner-Pammer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial
- (2009) S. A. STOCH et al. JOURNAL OF RHEUMATOLOGY
- Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2009) David M Reid et al. LANCET
- Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis
- (2009) T. Beukelman et al. OSTEOPOROSIS INTERNATIONAL
- Preferences of GPs and Patients for Preventive Osteoporosis Drug Treatment
- (2009) Esther W. de Bekker-Grob et al. PHARMACOECONOMICS
- How antirheumatic drugs protect joints from damage in rheumatoid arthritis
- (2008) Georg Schett et al. ARTHRITIS AND RHEUMATISM
- Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss
- (2008) Feng-Sheng Wang et al. ENDOCRINOLOGY
- Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3β
- (2008) Sun-Il Yun et al. JOURNAL OF BONE AND MINERAL METABOLISM
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started